Biotechnology BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update March 30, 2022
Biotechnology Lifshitz Law PLLC Announces Investigations of Desktop Metal, Inc. (NYSE: DM), Marathon Digital Holdings Inc. (NASDAQ: MARA), Reata Pharmaceuticals, Inc. (NASDAQ: RETA), and Robinhood Markets, Inc. (NASDAQ: HOOD) March 29, 2022
Biotechnology Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA March 29, 2022
Biotechnology BridgeBio Pharma to Present Updated Results from Phase 2 Open-label Extension Study of Acoramidis in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the American College of Cardiology (ACC) Annual Scientific Session & Expo March 28, 2022